This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Kyoto University. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Innovations of Katsumori Segawa
Introduction
Katsumori Segawa is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of cell biology. With a total of 3 patents, his work focuses on the mechanisms of cell engulfment and the role of specific inhibitors.
Latest Patents
One of his latest patents is a method for screening ATP11C or CDC50A inhibitors. This invention relates to a method for screening an inhibitor of ATP11C or CDC50A, which includes determining the exposure of phosphatidylserine on the cell surface, the engulfment of cells by macrophages, or the cleavage of ATP11C by caspase. Additionally, this invention also encompasses a method for inducing the engulfment of cells by macrophages through the inhibition of ATP11C or CDC50A.
Career Highlights
Katsumori Segawa is affiliated with Kyoto University, where he conducts his research and development activities. His work has been instrumental in advancing our understanding of cellular processes and their implications in health and disease.
Collaborations
He collaborates with Shigekazu Nagata, a fellow researcher, to further explore the intricacies of cell biology and the potential therapeutic applications of their findings.
Conclusion
Katsumori Segawa's innovative work in the field of biochemistry highlights the importance of understanding cellular mechanisms. His contributions through patents and research continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile